CAM
OSIR

ClariVest Asset Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

ClariVest Asset Management’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-17,500
Closed -$323K – 692
2015
Q3 		$323K Buy
17,500
+100
+0.6% +$1.93K 0.01% 361
2015
Q2 		$339K Buy
+17,400
New +$308K 0.01% 359

Other funds holding OSIR

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QI
QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return

ClariVest Asset Management's OSIR Position: Q4 2015 in Review

ClariVest Asset Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q4 2015, closing a stake of 17,500 shares — an estimated $323K sold.

ClariVest Asset Management first reported a position in OSIR in Q2 2015 and held it in 2 quarters. The position peaked at $339K in Q2 2015. 81 funds tracked by Wall St. Rank hold OSIR as of Q4 2015.

  • ClariVest Asset Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • ClariVest Asset Management sold 17,500 Osiris Therapeutics, Inc. Common Stock shares in Q4 2015, an estimated $323K.
  • ClariVest Asset Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2015 and held it in 2 quarters.
  • ClariVest Asset Management's Osiris Therapeutics, Inc. Common Stock position peaked at $339K in Q2 2015.
  • 81 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q4 2015.

Based on ClariVest Asset Management's 13F filing for Q4 2015, filed 27 Jan 2016.